Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Non-muscle myosin II is a major cytoskeletal molecular motor protein complex, responsible for ATP-dependent contractile force generation in nearly all eukaryotic cells outside of muscle tissue[3][4][5][6]. Structurally, it is a hexamer composed of two heavy chains (encoded by MYH9/10/14 for isoforms NM IIA/IIB/IIC), two essential light chains, and two regulatory light chains[3][4][5][6]. It dynamically assembles into bipolar filaments that interact with actin filaments to drive processes such as cytokinesis, cell migration, shape change, mechanotransduction, and maintenance of tissue architecture[3][4][5][6][1]. Distinct NM II isoforms (A, B, C) have specialized and overlapping cellular functions, with mutations or dysregulation implicated in numerous diseases including cancer metastasis, cardiovascular disorders, developmental defects, and specific hereditary syndromes[6][1]. NM II activity and assembly are tightly regulated through phosphorylation of regulatory light chains and various signaling pathways[2][5]. Selective inhibition of non-muscle myosin II is under investigation for conditions involving abnormal cell migration, contractility, or division.
Inhibition of myosin II ATPase activity (by blebbistatin and related) Blockade of actomyosin contractility/filament formation
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Non-muscle myosin II (NM II).